{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T18:58:16Z","timestamp":1766516296231},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T00:00:00Z","timestamp":1709337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T00:00:00Z","timestamp":1709337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Prim. Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Polypharmacy is easily achieved in elderly patients with multimorbidity and it is associated with a higher risk of potentially inappropriate medication use and worse health outcomes. Studies have shown that deprescription is safe, however, some barriers have been identified. The aim of this study was to analyse Portuguese General Practitioners (GP) deprescription\u2019s attitudes using clinical vignettes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Cross-sectional study using an online survey with 3 sections: demographic and professional characterization; two clinical vignettes with an elderly patient with multimorbidity and polypharmacy in which the dependency level varies; barriers and factors influencing deprescription. Frequencies, means, and standard deviations were calculated to describe the GPs. Analysis of the deprescription attitude, globally and for each drug, for each clinical vignette applying the McNeemar\u2019s test.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A sample of 396 GP was obtained with a mean age of 38 years, most of them female. A statistically significant difference (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01) was observed in deprescribing according to the patient dependency level, with more GPs (80.4% versus 75.3%) deprescribing in the most dependent patient. A statistically significant difference was found for all drugs except for antihypertensive drugs. All medications were deprescribed more often in dependent patients except for anti-dementia drugs. More than 70% of the participants considered life expectancy and quality of life as \u201cvery important\u201d factors for deprescription and more than 90% classified the existence of guidelines and the risks and benefits of medication as \u201cvery important\u201d or \u201cimportant\u201d. In the open question, the factors most reported by the GP were those related to the patient (52,9%).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This is the largest study on this topic carried out in Portugal using clinical vignettes, with a representative sample of Portuguese GP. The level of dependence significatively influenced the deprescription attitude of Portuguese GPs. The majority of the GPs classified the quality of life, life expectancies, potential negative effects and the existence of guidelines as \u201cvery important\u201d or \u201cimportant\u201d while deprescribing. It is important to develop and test deprescribing in real life studies to analyze if these attitudes are the same in daily practice.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12875-024-02299-3","type":"journal-article","created":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T06:01:21Z","timestamp":1709359281000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Evaluation of deprescription by general practitioners in elderly people with different levels of dependence: cross-sectional study"],"prefix":"10.1186","volume":"25","author":[{"given":"T\u00e2nia","family":"Coelho","sequence":"first","affiliation":[]},{"given":"In\u00eas","family":"Rosendo","sequence":"additional","affiliation":[]},{"given":"Carlos","family":"Sei\u00e7a Cardoso","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,3,2]]},"reference":[{"issue":"1","key":"2299_CR1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12875-018-0856-9","volume":"19","author":"S Mantelli","year":"2018","unstructured":"Mantelli S, Jungo KT, Rozsnyai Z, Reeve E, Luymes CH, Poortvliet RKE, et al. How general practitioners would deprescribe in frail oldest-old with polypharmacy \u2014 the LESS study. BMC Fam Pract. 2018;19(1):169.","journal-title":"BMC Fam Pract"},{"issue":"9","key":"2299_CR2","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jclinepi.2012.02.018","volume":"65","author":"D Gnjidic","year":"2012","unstructured":"Gnjidic D, Hilmer SN, Blyth FM, Naganathan V, Waite L, Seibel MJ, et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol. 2012;65(9):989\u201395.","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"2299_CR3","first-page":"436","volume":"66","author":"K McGrath","year":"2017","unstructured":"McGrath K, Hajjar ER, Kumar C, Hwang C, Salzman B. Deprescribing: a simple method for reducing polypharmacy. J Fam Pract. 2017;66(7):436\u201345.","journal-title":"J Fam Pract"},{"key":"2299_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1471-2296-13-56","volume":"13","author":"J Schuling","year":"2012","unstructured":"Schuling J, Gebben H, Veehof LJ, Haaijer-Ruskamp FM. Deprescribing medication in very elderly patients with multimorbidity: the view of Dutch GPs. A qualitative study. BMC Fam Pract. 2012;13:56.","journal-title":"BMC Fam Pract"},{"issue":"4","key":"2299_CR5","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s11606-019-04837-7","volume":"34","author":"Y Schenker","year":"2019","unstructured":"Schenker Y, Park SY, Jeong K, Pruskowski J, Kavalieratos D, Resick J, et al. Associations between Polypharmacy, Symptom Burden, and quality of life in patients with Advanced, Life-limiting illness. J Gen Intern Med. 2019;34(4):559\u201366.","journal-title":"J Gen Intern Med"},{"issue":"7","key":"2299_CR6","doi-asserted-by":"publisher","first-page":"e019542","DOI":"10.1136\/bmjopen-2017-019542","volume":"8","author":"PA Sim\u00f5es","year":"2018","unstructured":"Sim\u00f5es PA, Santiago LM, Sim\u00f5es JA. Deprescribing in primary care in Portugal (DePil17-20): a three-phase observational and experimental study protocol. BMJ Open. 2018;8(7):e019542.","journal-title":"BMJ Open"},{"key":"2299_CR7","doi-asserted-by":"crossref","unstructured":"Santiago LM, Prazeres F, Boto T, Maur\u00edcio K, Rosendo I, Sim\u00f5es JA. Multimorbidity daily life activities and socio-economic classification in the Central Portugal primary health care setting: an observational study 2020;22(1):54\u20138.","DOI":"10.5114\/fmpcr.2020.92506"},{"key":"2299_CR8","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.2147\/PPA.S219346","volume":"13","author":"PA Sim\u00f5es","year":"2019","unstructured":"Sim\u00f5es PA, Santiago LM, Maur\u00edcio K, Sim\u00f5es JA. Prevalence of potentially inappropriate medication in the older Adult Population within Primary Care in Portugal: a nationwide cross-sectional study. Patient Prefer Adherence. 2019;13:1569\u201376.","journal-title":"Patient Prefer Adherence"},{"issue":"12","key":"2299_CR9","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.2165\/11319530-000000000-00000","volume":"26","author":"J Jyrkk\u00e4","year":"2009","unstructured":"Jyrkk\u00e4 J, Enlund H, Korhonen MJ, Sulkava R, Hartikainen S. Polypharmacy status as an indicator of mortality in an elderly population. Drugs Aging. 2009;26(12):1039\u201348.","journal-title":"Drugs Aging"},{"issue":"6","key":"2299_CR10","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1093\/ageing\/afz109","volume":"48","author":"HJ Woodford","year":"2019","unstructured":"Woodford HJ, Fisher J. New horizons in deprescribing for older people. Age Ageing. 2019;48(6):768\u201375.","journal-title":"Age Ageing"},{"issue":"10081","key":"2299_CR11","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1016\/S0140-6736(17)31188-1","volume":"389","author":"PA Rochon","year":"2017","unstructured":"Rochon PA, Gurwitz JH. The prescribing cascade revisited. Lancet. 2017;389(10081):1778\u201380.","journal-title":"Lancet"},{"issue":"4","key":"2299_CR12","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1093\/ageing\/afv028","volume":"44","author":"NC D NC, C","year":"2015","unstructured":"D NC, C NC, Beveridge A. Factors influencing deprescribing habits among geriatricians. Age Ageing. 2015;44(4):704\u20138.","journal-title":"Age Ageing"},{"issue":"2","key":"2299_CR13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/gerona\/glr084","volume":"67","author":"DG Le Couteur","year":"2012","unstructured":"Le Couteur DG, McLachlan AJ, de Cabo R. Aging, drugs, and drug metabolism. J Gerontol Biol Sci Med Sci. 2012;67(2):137\u20139.","journal-title":"J Gerontol Biol Sci Med Sci"},{"issue":"7","key":"2299_CR14","doi-asserted-by":"publisher","first-page":"547","DOI":"10.2165\/11592000-000000000-00000","volume":"28","author":"K Richardson","year":"2011","unstructured":"Richardson K, Ananou A, Lafortune L, Brayne C, Matthews FE. Variation over time in the association between polypharmacy and mortality in the older population. Drugs Aging. 2011;28(7):547\u201360.","journal-title":"Drugs Aging"},{"issue":"8","key":"2299_CR15","first-page":"19","volume":"21","author":"D Opondo","year":"2012","unstructured":"Opondo D, Eslami S, Visscher S, de Rooij SE, Verheij R, Korevaar JC, et al. Inappropriateness of medication prescriptions to elderly patients in the primary care setting: a systematic review. PLoS ONE. 2012;21(8):19.","journal-title":"PLoS ONE"},{"issue":"10","key":"2299_CR16","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s40266-013-0106-8","volume":"30","author":"E Reeve","year":"2013","unstructured":"Reeve E, To J, Hendrix I, Shakib S, Roberts MS, Wiese MD. Patient barriers to and enablers of deprescribing: a systematic review. Drugs Aging. 2013;30(10):793\u2013807.","journal-title":"Drugs Aging"},{"issue":"10","key":"2299_CR17","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1111\/j.1532-5415.2006.00889.x","volume":"54","author":"MA Steinman","year":"2006","unstructured":"Steinman MA, Landefeld CS, Rosenthal GE, Berthenthal D, Sen S, Kaboli PJ. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc. 2006;54(10):1516\u201323.","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"2299_CR18","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s11096-012-9681-8","volume":"34","author":"MS Wahab","year":"2012","unstructured":"Wahab MS, Nyfort-Hansen K, Kowalski SR. Inappropriate prescribing in hospitalised Australian elderly as determined by the STOPP criteria. Int J Clin Pharm. 2012;34(6):855\u201362.","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"2299_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1136\/ejhpharm-2016-000967","volume":"24","author":"P Duncan","year":"2017","unstructured":"Duncan P, Duerden M, Payne RA. Deprescribing: a primary care perspective. Eur J Hosp Pharm. 2017;24(1):37\u201342.","journal-title":"Eur J Hosp Pharm"},{"issue":"5","key":"2299_CR20","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jamainternmed.2015.0324","volume":"175","author":"IA Scott","year":"2015","unstructured":"Scott IA, Hilmer SN, Reeve E, Potter K, Le Couteur D, Rigby D, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175(5):827\u201334.","journal-title":"JAMA Intern Med"},{"issue":"1","key":"2299_CR21","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1186\/s12877-020-01870-8","volume":"20","author":"S Zechmann","year":"2020","unstructured":"Zechmann S, Senn O, Valeri F, Essig S, Merlo C, Rosemann T, et al. Effect of a patient-centred deprescribing procedure in older multimorbid patients in Swiss primary care - A cluster-randomised clinical trial. BMC Geriatr. 2020;20(1):471.","journal-title":"BMC Geriatr"},{"key":"2299_CR22","unstructured":"Silva G, Cardoso C, Silva I. Factors influencing deprescribing decision of primary care phisicians in Portugal. Trabalho final do Mestrado Integrado em Medicina da FMUC; 2022."},{"issue":"12","key":"2299_CR23","doi-asserted-by":"publisher","first-page":"e006544","DOI":"10.1136\/bmjopen-2014-006544","volume":"4","author":"K Anderson","year":"2014","unstructured":"Anderson K, Stowasser D, Freeman C, Scott I. Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis. BMJ Open. 2014;4(12):e006544.","journal-title":"BMJ Open"},{"issue":"1","key":"2299_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12877-020-01953-6","volume":"21","author":"KT Jungo","year":"2021","unstructured":"Jungo KT, Mantelli S, Rozsnyai Z, Missiou A, Kitanovska BG, Weltermann B, et al. General practitioners\u2019 deprescribing decisions in older adults with polypharmacy: a case vignette study in 31 countries. BMC Geriatr. 2021;21(1):19.","journal-title":"BMC Geriatr"},{"issue":"12","key":"2299_CR25","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1001\/jamainternmed.2015.5110","volume":"175","author":"JB Sussman","year":"2015","unstructured":"Sussman JB, Kerr EA, Saini SD, Holleman RG, Klamerus ML, Min LC, et al. Rates of deintensification of blood pressure and glycemic medication treatment based on levels of control and life expectancy in older patients with diabetes Mellitus. JAMA Intern Med. 2015;175(12):1942\u20139.","journal-title":"JAMA Intern Med"},{"issue":"1","key":"2299_CR26","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12877-017-0486-4","volume":"17","author":"S Streit","year":"2017","unstructured":"Streit S, Verschoor M, Rodondi N, Bonfim D, Burman RA, Collins C, et al. Variation in GP decisions on antihypertensive treatment in oldest-old and frail individuals across 29 countries. BMC Geriatr. 2017;17(1):93.","journal-title":"BMC Geriatr"},{"issue":"5","key":"2299_CR27","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1001\/jamainternmed.2015.0289","volume":"175","author":"JS Kutner","year":"2015","unstructured":"Kutner JS, Blatchford PJ, Taylor DH Jr., Ritchie CS, Bull JH, Fairclough DL, et al. Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial. JAMA Intern Med. 2015;175(5):691\u2013700.","journal-title":"JAMA Intern Med"},{"issue":"1","key":"2299_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1179\/174329111X576698","volume":"19","author":"AR Maddison","year":"2011","unstructured":"Maddison AR, Fisher J, Johnston G. Preventive medication use among persons with limited life expectancy. Prog Palliat Care. 2011;19(1):15\u201321.","journal-title":"Prog Palliat Care"},{"issue":"1","key":"2299_CR29","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/jgs.16157","volume":"68","author":"P Goyal","year":"2020","unstructured":"Goyal P, Anderson TS, Bernacki GM, Marcum ZA, Orkaby AR, Kim D, et al. Physician perspectives on Deprescribing Cardiovascular medications for older adults. J Am Geriatr Soc. 2020;68(1):78\u201386.","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"2299_CR30","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.jpainsymman.2016.12.350","volume":"53","author":"A Poudel","year":"2017","unstructured":"Poudel A, Yates P, Rowett D, Nissen LM. Use of preventive medication in patients with Limited Life Expectancy: a systematic review. J Pain Symptom Manage. 2017;53(6):1097\u2013110e1.","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"2299_CR31","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/gps.4006","volume":"29","author":"C Parsons","year":"2014","unstructured":"Parsons C, McCorry N, Murphy K, Byrne S, O\u2019Sullivan D, O\u2019Mahony D, et al. Assessment of factors that influence physician decision making regarding medication use in patients with dementia at the end of life. Int J Geriatr Psychiatry. 2014;29(3):281\u201390.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"8","key":"2299_CR32","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1111\/j.1532-5415.2009.02376.x","volume":"57","author":"Pharmacological management of","year":"2009","unstructured":"Pharmacological management of. Persistent pain in older persons. J Am Geriatr Soc. 2009;57(8):1331\u201346.","journal-title":"J Am Geriatr Soc"},{"key":"2299_CR33","volume-title":"opi\u00f3ides fortes na dor cr\u00f3nica n\u00e3o oncol\u00f3gica","author":"Utiliza\u00e7\u00e3o dos medicamentos","year":"2008","unstructured":"Utiliza\u00e7\u00e3o dos medicamentos. opi\u00f3ides fortes na dor cr\u00f3nica n\u00e3o oncol\u00f3gica. Circular Informativa: Dire\u00e7\u00e3o-Geral da Sa\u00fade; 2008."}],"container-title":["BMC Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-024-02299-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12875-024-02299-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-024-02299-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T06:01:45Z","timestamp":1709359305000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcfampract.biomedcentral.com\/articles\/10.1186\/s12875-024-02299-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,2]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2299"],"URL":"https:\/\/doi.org\/10.1186\/s12875-024-02299-3","relation":{},"ISSN":["2731-4553"],"issn-type":[{"value":"2731-4553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,2]]},"assertion":[{"value":"20 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approved by the Ethics Committee of the Faculty of Medicine of the University of Coimbra. The study objectives were listed in writing prior to obtaining informed consent from all participants. Participants\u2019 confidentiality was guaranteed. The methodology adopted respects ethical principles such as the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"78"}}